As a complementary approach, ex vivo assays were performed to deepen into the involvement of insulin in obesity-related erythroid disturbances, discarding potential confounding interferences derived from the complex systemic environment. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.